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Clinical and social consequences of Buerger
disease
Takashi Ohta, MD, Hiroyuki Ishioashi, MD, Minoru Hosaka, MD, and Ikuo Sugimoto, MD, Aichi, Japan
Purpose: This study was undertaken to assess the clinical course of Buerger disease and to analyze the social problems that
influence quality of life of affected patients.
Patients and methods: One hundred ten patients with Buerger disease (106 men, 4 women; mean age, 40.0 years) for
whom complete data since onset of disease were available were included in this retrospective study (mean follow-up, 10.6
years). Data were obtained by means of direct interview, written reports, or telephone. Data for deceased subjects were
gathered from their families via written report or telephone. Graft patency was evaluated by means of ankle pressure
measurement; and in all patients with decreased ankle pressure arteriography was performed.
Results: Seven of 110 study patients (6%) died during follow-up. Cumulative survival rate was 84% up to 25 years after the
initial consultation. Results of bypass operations (n 46) were not satisfactory. Primary graft patency was 41% at 1 year
after operation, 32% at 5 years, and 30% at 10 years. Secondary graft patency was 54% at 1 year of follow-up, 47% at 5
years, and 39% at 10 years. However, major amputation was necessary in only 5 of 35 limbs (14%) with failed grafts.
Forty-seven patients (43%) underwent 108 amputation procedures, either major amputation (13 patients) or minor
amputation (34 patients), of an upper or lower limb. No ischemic ulcers occurred or recurred in patients older than 60
years. Forty-one patients who stopped smoking did not undergo major amputation. Furthermore, of 69 patients who
continued smoking, 13 patients (19%) underwent major amputation. There was a correlation between incidence of
continued smoking and limb amputation (P  .0070). In addition, 11 of 13 patients who underwent major lower limb
amputation (85%) lost their job, compared with 9 of 97 patients without major amputation (9%). There was an
association between limb amputation and job loss (P < .0001). All patients who lost their jobs were engaged in manual
labor.
Conclusion: The natural course of life and limb is favorable in many patients with Buerger disease. Occurrence or
recurrence of necrotic lesions usually is arrested in patients older than 60 years. To avoid factors that markedly influence
quality of life, early treatment and strict instruction to prohibit smoking are mandatory. Arterial reconstruction shortens
the healing process of ischemic ulcers, despite poor long-term results. However, bypass surgery to treat intermittent
claudication should be limited. (J Vasc Surg 2004;39:176-80.)
Buerger disease is characterized by peripheral arterial
occlusive disease in young male smokers. The prognosis for
life in patients with the disease is favorable,1-3 but the high
incidence of necrotic lesions not only requires prolonged
hospitalization, but can also result in major or minor am-
putation in many patients. We were surprised to find that
the number of patients with Buerger disease who visit
outpatient clinics and are admitted to hospitals has de-
creased in Japan. It is helpful to know the details of the
clinical course and social consequence of this vanishing
disease.4
PATIENTS AND METHODS
Between January 1, 1978, and June 30, 2001, 154
patients with Buerger disease were admitted to Aichi Med-
ical University Hospital. Buerger disease was diagnosed on
the basis of the five clinical criteria of Shionoya2: smoking
history, onset before age 50 years, infrapopliteal arterial
occlusive disease, either upper limb involvement or phlebi-
tis migrans, and absence of atherosclerotic risk factors other
than smoking. Patients with collagen disease, popliteal
entrapment syndrome, cystic adventitial disease, hyperco-
agulable state, thoracic outlet syndrome, and atrial fibrilla-
tion were excluded from the study. Of the 154 patients,
110 patients for whom complete data since onset of disease
were available were included in this retrospective study.
Clinical history and findings at physical examination were
recorded for all patients. Infrapopliteal arterial involvement
was diagnosed at arteriography in all patients. Upper limb
involvement was usually determined on the basis of history
and physical findings (Allen test). Arteriography was per-
formed only in patients with symptoms consistent with
involvement of the upper limbs.
Follow-up information included all therapy performed
for Buerger disease, presence or absence of limb amputa-
tion, loss of job, continued smoking, and education. For
survivors, this information was obtained by means of direct
interview, written report, or telephone survey; for nonsur-
vivors, data were obtained from the patient’s family via
written report or telephone survey. Graft patency was de-
termined by ankle pressure measurement. Arteriography
was performed in all patients in whom ankle pressure de-
creased. However, when direct confirmation was impossi-
ble, graft patency was evaluated as unclear.
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Statistical analysis. Graft patency (primary, second-
ary), limb salvage, and survival rates were calculated with
the life table method. Associations were tested with the 2
test.
RESULTS
Complete data from onset of disease were available for
110 patients. Mean follow-up was 10.6 years. One hundred
six patients were men (96%), and 4 patients were women
(4%). Age at disease onset ranged from 17 to 49 years
(mean, 35 years). Age at initial consultation ranged from 20
to 65 years (mean, 40 years). All patients were smokers.
Forty-four patients were junior high school graduates, 46
were high school graduates, and 20 were university gradu-
ates. The disease involved the infrapopliteal arteries in 110
patients (100%) and the upper extremities in 74 patients
(67.3%), and 45 patients had a history of or current phle-
bitis migrans (40.9%). No patients had atherosclerotic risk
factors other than smoking. Before initial consultation in
our hospital, 7 patients (7 limbs) had undergone arterial
reconstruction, 34 patients (56 limbs) had undergone lum-
bar sympathectomy, and 7 patients (9 limbs) had under-
gone thoracic sympathectomy. At initial consultation, all
femorotibial bypass grafts constructed with autologous
vein were observed to be occluded. Amputations included
8 lower legs (1 above the knee, 7 below the knee), 11 feet,
21 toes, and 15 fingers. The stumps of the 2 feet, 5 toes,
and 3 fingers were not healed at presentation to our hospi-
tal.
Ischemic symptoms were observed in 134 lower limbs
in 99 patients and 43 upper limbs in 29 patients. The most
severe complaints during follow-up are shown in the Table.
Bypass surgery of the lower limbs was performed 46 times
in 31 patients (35 limbs) at our hospital. Bypass surgery was
indicated to treat intermittent claudication in 14 limbs
(30.4%), and resting pain, ulcer, or necrosis in 32 limbs
(69.6%). Ten of 46 arterial reconstructions were repeat
operations. Proximal anastomotic sites consisted of the
external iliac artery in 1 limb, common femoral artery in 13
limbs, superficial femoral artery in 29 limbs, and above-
knee popliteal artery in 3 limbs. Distal anastomotic sites
consisted of common femoral artery in 1 limb, above-knee
popliteal artery in 3 limbs, below-knee popliteal artery in 8
limbs, and crural arteries in 34 limbs. In patients with
iliofemoral bypass surgery with autologous vein, skipped
lesions were observed in the external iliac and tibial arteries.
Infrapopliteal arterial reconstruction was performed in 42
limbs (91.3%). In 39 limbs (84.7%), autologous vein, in-
cluding arm veins in 6 limbs, was used. In 7 limbs without
available autologous vein (4.1%), prosthetic grafts, bovine
grafts, or composite grafts were used. Concomitant lumbar
sympathectomy was performed in 2 limbs. In 26 patients
(26 limbs), lumbar sympathectomy was performed. Sym-
pathectomy was indicated to treat intermittent claudication
in 8 limbs (30.8%), and resting pain, ulcer, or necrosis in 18
limbs (69.2%). Thoracic sympathectomy was performed in
2 patients (2 limbs) with ischemic ulcer.
In all patients except those admitted for examination (8
limbs), vasoactive agents, anticoagulants, or antiplatelet
agents were administered at admission. In patients with
ulcer, fibrinolytic agents or vasoactive agents were pre-
scribed in accordance with the condition. The agents pre-
scribed, and patient compliance after discharge were un-
clear in many patients.
Life outcome. During follow-up, 19 patients had nu-
merous diseases that were considered atherosclerotic risk
factors after initial consultation, including diabetes mellitus
in 8 patients (mean time after onset of Buerger disease,
20.8 years), hyperlipidemia in 6 patients (mean time after
onset, 9.3 years), and hypertension in 5 patients (mean time
of onset, 18.5 years). Fourteen patients had life-threaten-
ing diseases, with fatal outcome, including cerebrovascular
disease in 5 patients, ischemic heart disease in 4 patients,
malignant disease in 4 patients, and heart failure in 1
patient. Seven patients (6.4%) died during follow-up. The
causes of death were cerebral hemorrhage in 2 patients,
malignant disease in 1 patient, heart failure in 1 patient,
suicide in 1 patient, and cause unclear in 2 patients. Anti-
coagulation therapy was not performed in two patients with
cerebral hemorrhage. Cumulative survival rate after initial
consultation was 97.0% at 5 years, 94.4% at 10 years, 92.4%
at 20 years, and 83.8% at 25 years (Fig 1).
Outcome of bypass surgery. In 31 patients (35
limbs) who underwent arterial reconstruction of the lower
limbs (total, 46 procedures), primary graft patency rate
after 46 arterial reconstructions was 41.3% at 1 year, 32.2%
at 5 years, and 29.7% at 10 years. Secondary graft patency
rate was 54.3% at 1 year, 47.4% at 5 years, and 39.4% at 10
years (Fig 2). All bypasses in which prosthetic grafts, bovine
grafts, or composite grafts were used were found to be
occluded within 10 months. In patients with graft prob-
lems, progression of proximal or distal disease was noted in
11 patients, stenosis of the anastomotic site in 6 patients,
autologous vein graft stenosis in 6 patients, technical failure
in 5 patients, and unknown factors in 11 patients.
Major amputation was necessary in 5 of 35 limbs
(14.3%) with failed grafts (above knee, 2; below knee, 3).
No amputations were performed in patients with a patent
Most severe symptoms during clinical course of Buerger disease
Cold, cyanosis Claudication Rest pain Ulcer, gangrene Phlebitis migrans Total
Lower limb 9 23* 8 97 3 134
Upper limb 11 0 0 32 0 43
*Sole, 15; calf, 8.
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graft. Limb salvage rates were 91.4% at 1 year, 88.6% at 5
years, and 85.4% at 10 years after the operation (Fig 3).
Outcome of limb. Forty-seven (42.7%) of 110 pa-
tients underwent either major or minor amputation of the
lower or upper limb after onset, for a total of 108 proce-
dures (lower limb, 34 patients; upper limb, 3 patients; both
lower and upper limbs, 10 patients). Age at onset, age at
amputation, and interval between onset and amputation
are shown in Fig 4. No ischemic ulcer occurred or recurred
in patients older than 60 years. Major amputation was
performed in 16 limbs (above knee, 2; below knee, 14) in
13 patients (11.8%). Two patients underwent major ampu-
tation in other hospitals before the initial consultation,
eight patients in our hospital, and three patients in other
hospitals after discharge. Three patients underwent major
amputation of both lower limbs. Minor amputation was
performed in 34 patients. Thirteen patients (11.8%) under-
went either hand or finger amputation. Of these patients,
bilateral fingers were amputated in five patients. Forty-one
patients who stopped smoking underwent no major limb
amputation. Of 69 patients who continued smoking, major
limb amputation was performed in 13 patients (18.8%).
There was a correlation between continued smoking and
limb amputation (P  .0070). There was no difference
between continued smoking and educational level; how-
ever, all patients with major amputation were junior high
school or high school graduates.
Employment outcome. Employment conditions af-
ter the onset of disease were investigated in 110 patients.
Sixty-three patients (57.3%) continued in their jobs, and 24
patients (21.8%) left their jobs, mainly due to advanced age.
Three patients (2.7%) changed type of job, and 20 patients
(18.2%) lost their jobs. Eleven of 13 patients who under-
went major lower limb amputation lost their jobs (84.6%),
but only 9 of 97 patients without major amputation lost
their jobs (9.3%). There was an association between limb
amputation and loss of job (P  .0001). Regardless of
presence or absence of limb amputation, 20 patients who
lost their jobs were engaged in blue-collar jobs, such as
drivers, manual workers, carpenters, and plasterers.
DISCUSSION
Of 154 patients in the entire group of patients with
Buerger disease, 110 (71.4%) were followed up. Low fol-
low-up rate is also reported in the literature.5,6 The reason
for low rate of follow-up is that most patients are young and
are in a lower socioeconomic class and therefore often live
in rental houses and change their address often. Patients
with Buerger disease receive financial medical assistance,
and every year they must send a medical certificate to the
health center of the prefecture where they live. If they do
not return to our institution because of change of address
or remission of disease, follow-up is difficult.
The prognosis is favorable for most patients with
Buerger disease.1-3 In our series only seven patients (6.4%)
died during follow-up, and at 25 years after initial consul-
tation the survival rate was 83.8%. However, ischemic ulcer
occurred or recurred in about two thirds of patients with
onset at a young age. Once ischemic ulcer occurs, it is
important to prevent major amputation and prolonged
hospitalization, which markedly influence quality of life.
Although successful bypass surgery dramatically im-
proves symptoms of ischemia, it is not frequently applicable
in Buerger disease. Bypass surgery was indicated in only a
third of our patients, as a response to widespread arterial
Fig 2. Cumulative primary and secondary graft patency rates (%);
life table method.
Fig 3. Cumulative limb salvage rate (%) in 35 lower limbs with
bypass surgery; life table method.
Fig 1. Cumulative survival rate (%); life table method.
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occlusions at multiple sites, with prevalence in the distal
part of the limbs. The results of arterial reconstruction in
our hospital were no better than reported by Sasajima et al.7
Graft complications occurred frequently within 2 years after
surgery. Early graft failure (30 days) was extremely high,
as a result of poor technique, poor graft quality, or poor
runoff vessels. Intermediate term graft failure (2 years)
was also high, caused by proliferative changes in the graft
itself or in the revascularized segment. Progression of the
underlying disease process is relatively rapid, despite admin-
istration of antiplatelet agents or anticoagulant therapy.
The graft patency rate was not satisfactory; however, am-
putation was necessary in only 7 limbs (16%). Even when
arterial reconstruction induces graft occlusion within a
short time, limb amputation can be avoided in many pa-
tients in whom ulcer healing is achieved during graft pa-
tency. Arterial reconstruction with use of autologous vein,
which can shorten the interval from surgery until ulcer
healing, should be considered, but must be limited to
patients with intermittent claudication.
Although treatment of ischemic symptoms is a prob-
lem, the purpose of treatment of Buerger disease is to
prevent occurrence or recurrence of ischemic ulcer. In our
series, 44 of 110 patients followed up (40.0%) were older
than 60 years. No ischemic ulcer occurred and no minor or
major amputation was performed in these patients. In
contrast to arteriosclerosis obliterans, it is thought that
there is an active phase of disease during the clinical course
of Buerger disease. Onset or duration of the active phase
may differ among patients, but is arrested after age 60 years
(Fig 4).
While the cause of Buerger disease is not yet clear,
smoking is closely related to exacerbation and remission of
the disease.3,5 Forty-one patients who stopped smoking
underwent no limb amputation. Of 69 patients who con-
tinued smoking, 13 underwent major amputation; that is,
all patients who lost limbs did not abstain from smoking.
There was a correlation between continued smoking and
limb amputation (P .0070). However, it is also true that
not every patient who continued to use tobacco required
limb amputation. The rate of continued smoking after
initial consultation was highest in junior high school grad-
uates, followed by senior high school graduates and univer-
sity graduates. However, there was no significant difference
between continued smoking and level of education. De-
spite these findings, limb amputation was performed only
in patients with less education, that is, junior and senior
high school graduates.
Few studies have reported rehabilitation in patients with
Buerger disease. Shionoya et al8 reported that 17 of 165
patients (10.3%) lost their job and that 30 patients (18.2%)
changed their occupation. Borner et al9 reported that 12 of 69
patients (17.4%) changed jobs, whereas 24 (34.8%) retired
early (mean age, 42 years). In our series, 23 of 110 patients
(20.9%) lost or changed jobs because of the disease. Of these
patients, 21 (91.3%) were junior or senior high school gradu-
ates, 20 (87.0%) were engaged in blue-collar jobs, and 9
patients (39.1%) underwent limb amputation.
Many junior or senior high school graduates are engaged
in blue-collar jobs, and in these jobs workers are discharged
because of prolonged absence and because there is no guar-
antee of stable work in Japan. Most patients must strive to
Fig 4. Age at onset of disease, age at amputation, and follow-up duration. Most patients underwent major amputation
(black circles) or minor amputation (white circles) 10 to 15 years after disease onset, although some patients underwent
amputation after a long interval with disease. It is interesting that no amputation was performed in patients older than
60 years. Progression of Buerger disease may subside after age 60 years, and symptoms of ischemia are not influenced
by atherosclerotic arterial changes with age.
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work because they are the main breadwinner in the family.
Therefore they may postpone hospitalization, even with ulcer,
and thus the severe ischemia that ensues may later result in
limb amputation. Early treatment may be necessary to prevent
deterioration of lesions and exacerbation of symptoms.
The cause of Buerger disease is unknown, but the
natural course of life and limb is favorable for many pa-
tients. Occurrence or recurrence of necrotic lesions usually
subsides after age 60 years. To avoid factors that markedly
influence quality of life, early treatment should be provided,
along with strict instruction to abstain from smoking. Ar-
terial reconstruction, despite failure, shortens the healing
process of ischemic ulcer. However, bypass surgery must be
limited to treat intermittent claudication.
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